Are you a biopharma startup focused on oncology? A devices /diagnostics startup focused on cardiology? Or a health tech startup focused on how consumers/employers are addressing women’s health? If so, submit an application for MedCity INVEST Pitch Perfect by February 29!
Hospitals are places of healing, but they have also become sites of gun violence. A panel at the MedCity News INVEST conference discussed the ways hospitals can reduce threats and de-escalate situations before they become violent.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Multiple efforts are underway to improve cell therapies for cancer. During the MedCity News INVEST conference in Chicago, a panel discussed the future of cell therapies and what the industry doing to manage the financial risks of these new treatments.
A panel during the MedCity News INVEST conference discussed what digital health technologies need to do to demonstrate return on investment for payers, providers, and other stakeholders.
In just 2020, deaths from gun violence cost the U.S. healthcare system $290 million, or about $6,400 per patient, according to a report from the Commonwealth Fund. These costs are mostly covered by Medicaid and other government insurance programs.
The conference takes place March 28-30 at the Ritz Carlton hotel in Chicago. Register now and be part of the conversation, take part in networking opportunities and check out startup pitches across pharma tech, medtech, diagnostics, and digital health.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
The point of care diagnostics and testing market has climbed dramatically with the rise of the Covid-19 public health crisis. We're seeking applications for diagnostics startups who would like to take part in INVEST Pitch Perfect Diagnostics 2.0 track at the conference, scheduled to take place March 28-30 in Chicago.
The application window is open for the startup contest Pitch Perfect at INVEST March 28-30 at the Ritz Carlton in Chicago. Here's a look at some of the participants in the contest and progressed they've made on their mission to improve healthcare.
Apply to the startup pitch contest if you belong to any one of the following healthcare verticals – biopharma, medical devices, diagnostics, health IT or health services. The deadline to apply is 5pm ET, Friday, January 15.
Judges picked Parallel Profile as the winner of the health IT track at MedCity INVEST Precision Medicine. The startup is working to combat adverse drug reactions by making pharmacogenomic testing easier to access and interpret.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Today is the final day to save $300 when you register for healthcare investment conference MedCity INVEST.
Prior to speaking at the upcoming MedCity INVEST conference in Chicago, panelists Jessica Zeaske and Dr. Akhil Saklecha weighed in on what differentiates provider-led and payer-led funds from traditional VCs.
At MedCity INVEST, Alyssa Jaffee, senior associate at Pritzker Group Venture Capital, gave healthcare startups a pointer by putting a twist on the famous line from "Field of Dreams."
2016 is far from over, and in these last five years, payers have poured $900 million into digital health. Here's where and how some are making bets.
Sparrow Pharmaceuticals won the therapeutics category as part of this year’s Best of INVEST awards. Corticosteroids are an important anti-inflammatory treatment agent for a variety of medical conditions – ranging from autoimmune to cancer to organ transplants. However, chronic use of these drugs can lead to a similarly wide range of side effects. Sparrow Pharmaceuticals has brushed the dust […]